Embryonic Stem Cell Research: Ethics, Politics, and Promise
This paper examines embryonic stem cell research from ethical, political, and scientific perspectives, arguing that federal funding restrictions are counterproductive and that most moral objections can be addressed through continued research. The paper explains the biology of embryonic stem cells, surveys opposition from religious and pro-life groups, and critiques President Bush's 2006 veto of expanded funding legislation. It contends that the majority of Americans support federal investment in stem cell research, that restricting such funding merely redistributes resources or drives research abroad, and that the therapeutic potential of embryonic stem cells for diseases such as Parkinson's, Alzheimer's, diabetes, and spinal cord injuries justifies moving forward responsibly.
- Introduction to Embryonic Stem Cell Research: Overview of the debate and its public significance
- Understanding Stem Cells: Biology and Types: Biology of stem cells, pluripotency, and blastocysts
- Moral and Religious Opposition to Stem Cell Research: Catholic, pro-life, and anti-abortion objections examined
- Political Opposition and the Bush Veto: Bush's 2006 veto and political resistance to funding
- The Case for Federal Funding and Scientific Progress: Arguments for research funding and therapeutic potential
- Public Opinion and the Broader Ethical Debate: Polling data and nuanced pro-life support for research
- Conclusion: Federal funding as moral imperative for patient welfare
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper systematically presents opposing viewpoints — moral, religious, and political — before methodically refuting each, demonstrating strong argumentative structure.
- It grounds abstract ethical debate in concrete scientific concepts (totipotency, pluripotency, blastocyst development), giving readers the biological literacy needed to evaluate the claims.
- The use of polling data (NBC/Wall Street Journal, University of Pennsylvania Annenberg Survey) strengthens the policy argument with empirical evidence about public attitudes.
Key academic technique demonstrated
The paper employs a classic refutation essay structure: it fairly summarizes opposition arguments (Catholic Church position, pro-life objections, adult stem cell alternatives) before introducing counterarguments. This "steelman then rebut" approach signals intellectual honesty and is a valuable technique for persuasive academic writing on contested ethical issues.
Structure breakdown
The essay opens with a thesis statement and situates the debate in its social and regulatory context. Two middle sections establish biological foundations and then catalog moral and political objections. The argumentative core that follows addresses each objection in turn, incorporating scientific developments (e.g., the 2005 Harvard discovery), economic analysis of funding redistribution, and public opinion data. The conclusion synthesizes the stakes, framing responsible federal investment as a moral imperative for patients with incurable diseases.
Introduction to Embryonic Stem Cell Research
Embryonic stem cell research is not practically "embryonic," and most of the ethical objections raised against it could be resolved through further research. Restricting federal funding would not halt embryonic stem cell research; it would only lead to a redistribution of research funds. Moreover, the majority of Americans support embryonic stem cell research, which is essential for treating those who suffer from serious diseases.
Research on stem cells has been vehemently criticized both politically and morally, drawing biologists into ethical debates and generating tremendous public enthusiasm in this area of biology (Lovell-Badge, 88). Why does stem cell research attract such broad public interest? In large part because it requires government funding. Its prospects for international collaboration also create the need for regulations governing such exchanges. Ultimately, the possibility that stem cell research could lead to marketable medical products necessitates input from the Food and Drug Administration (Bobrow, 140). Much of the debate, however, has been conducted on an emotional basis, pitting the hope of treating acute medical conditions against the moral convictions of many Americans. To reach an informed conclusion on human embryonic stem cell research, it is essential to understand clearly what embryonic stem cells are and to assess more precisely the realistic medical benefits they may provide (Condic, 31).
Understanding Stem Cells: Biology and Types
Scientists have been aware of stem cells for many decades, but it was only in 1998 that a method was devised for culturing these cells from human embryos over extended periods and through multiple cell divisions (Marwick, 1192). Stem cells are defined as cells with the power to develop into any of the approximately 300 different types of cells in the human body (Perrone, A5). They are remarkable for their capacity to self-renew and to differentiate into varied cell types. Some stem cells are classified as totipotent, possessing an enormous capability to self-renew and become distinct cell types. Embryonic stem cells are pluripotent, meaning they can generate tissues from all three germ layers, yet are incapable of constituting an entire living organism (Cogle; Guthrie; Sanders; Allen; Scot; Petersen, 993).
In an adult organism, as stem cells undergo division, some progeny develop into specialized cell types such as heart or muscle cells, while others remain as stem cells, prepared to divide again to produce new specialized cells to address the body's daily wear and tear. Such stem cells are potent enough to regenerate and renew tissue indefinitely over a human lifetime (John, 47).
Another type of stem cell is found in the human embryo. The human embryo begins as a single totipotent cell, created when a sperm fertilizes an egg. A totipotent cell can develop into an embryo, the tissues needed to support the embryo in the uterus, and all the tissues and organs that ultimately form the adult human. As embryonic development proceeds, stem cells begin to specialize. They form a hollow sphere known as a blastocyst, which contains an outer cell mass that will become the placenta and an inner cell mass that will become all the tissues of the human body. The cells in the inner cell mass are called pluripotent because, although they cannot form the supporting tissues of the uterus, they are capable of generating almost any cell type in the human body. These pluripotent stem cells are at the center of the current ethical debate over the use of embryonic stem cells in research (John, 47).
Moral and Religious Opposition to Stem Cell Research
Understanding the moral and political opposition to stem cell research is essential for evaluating whether the debate is well founded (Cogle; Guthrie; Sanders; Allen; Scot; Petersen, 994). The most significant worldwide moral opposition comes from the Catholic Church, even though many individual American Catholics do not share this position. The official Catholic stance opposes in vitro fertilization on the grounds that it is unnatural and produces embryos that are not used (Stem Cell Research: News batch).
Anti-abortion groups oppose embryonic stem cell research because it results in the destruction of human embryos (Gareth; Byrne; Jones, 6). Many conservative pro-life individuals and organizations consider the destruction of a blastocyst — a laboratory-fertilized human egg — to be equivalent to ending a human life. They believe that life begins at conception and that terminating this pre-born life is morally offensive. They argue that it is unethical to destroy a days-old human embryo even for the purpose of saving or healing an existing human life (Pros & Cons of Embryonic Stem Cell Research). The Coalition of Americans for Research Ethics states: "Destroying human embryonic life is not required for making medical advances, as alternative forms of obtaining human stem cells and of repairing and regenerating human tissues exist and would continue to be developed" (Perrone, A5).
Many critics also argue that insufficient attention has been paid to the potential of adult stem cells, which have already been successfully used to treat various conditions. They contend that too little significance has been given to umbilical cord blood as a source for stem cell research. Opponents of embryonic stem cell research advocate directing grants primarily toward adult stem cell research in order to avoid the ethical concerns associated with the use of human embryos. They also note that no treatments have yet been produced through embryonic stem cell therapy (Pros & Cons of Embryonic Stem Cell Research).
Conclusion
The deficiency in federal support and the hostile political environment do hamper stem cell research in the United States. We are presently at a defining moment, looking toward liberation from the devastating effects of chronic illness. Embryonic stem cell research has the potential to generate important breakthroughs in the search for cures to some of the most common and most fatal diseases. As has been required of us in previous eras, we face the challenge of responsible leadership and of marshaling individual and collective effort to inform and shape the course of knowledge and understanding. The stakes are high, but the promise of a cellular approach to the repair of genetic dysfunction should drive us to apply our best efforts in service of our patients.
It should also be recognized that if we must decide in the future whether to use additional embryos to satisfy our growing need for cells, we will have overstated the moral decision of today. If we conclude rightly at that future moment not to destroy further embryos, we will nevertheless be far behind where we could have been in developing and applying stem cells from alternative sources — forced to rely on methods now considered unethical, and causing pain and suffering to those who lack access to therapeutic resources as a result of the harder ethical choices we failed to make earlier. We are squandering an opportunity to move in the right direction by arguing against stem cell research.
References
Birnbaum, Ben. Embryonic Stem Cell Research: Should Federal Funding be Expanded? The Cornell Daily Sun. 20 October 2006. pp. 4–5.
Bobrow, James C. The Ethics and Politics of Stem Cell Research. Transactions of the American Ophthalmological Society. December 2005. Vol. 103, No. 4, pp. 138–142.
Cogle, C.R.; Guthrie, S.M.; Sanders, R.C.; Allen, W.L.; Scot, E.W.; Petersen, B.E. An Overview of Stem Cell Research and Regulatory Issues. Mayo Clinic Proceedings. August 2003. Vol. 78, No. 8, pp. 993–1003.
Concerning Embryonic Stem Cell Research. 2001. Retrieved from Accessed 3 November 2006.
Condic, Maureen L. The Basics about Stem Cells. First Things. Vol. 119, No. 3. January 2002. pp. 30–34.
Deborah, White. Pros & Cons of Embryonic Stem Cell Research. Retrieved from Accessed 3 November 2006.
Gareth, D.; Byrne, Jones, Mary; Jones, Gareth. Stem Cell Research and Cloning. ATF Press. 2005.
John, Carol. Embryonic Stem Cell Research: An Ethical Justification. Georgetown Law Journal. January 2002. Vol. 26, No. 2, pp. 45–51.
Lovell-Badge, Robin. The Future for Stem Cell Research. Nature. Vol. 414. 1 November 2001. pp. 88–91.
Marwick, Charles. Embryonic Stem Cell Debate Brings Politics, Ethics to the Bench. Journal of the National Cancer Institute. Vol. 93, No. 16. August 15, 2001. pp. 1192–1193.
Perrone, Jane. Stem Cell Research. Guardian Unlimited. August 10, 2001. p. A5.
Perry, Daniel. Patients' Voices: The Powerful Sound in the Stem Cell Debate. Science. Vol. 287, No. 5457. 25 February 2000. p. 1423.
Schwartz, Robert S. The Politics and Promise of Stem-Cell Research. The New England Journal of Medicine. Vol. 355, No. 12. 21 September 2006. pp. 1189–1191.
Sherlock, Richard; Morrey, John D. Ethical Issues in Biotechnology. Rowman & Littlefield. 2002.
Stem Cell Research. August 2006. Retrieved from Accessed 3 November 2006.
The Economics of Stem-Cell Research — Posner. 20 August 2006. Retrieved from Accessed 3 November 2006.
Winston, Robert. Embryonic Stem Cell Research — The Case For… Nature Medicine. Vol. 7, No. 1. 2001. pp. 396–397.
Always verify citation format against your institution’s current style guide requirements.